This HTML5 document contains 97 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
wdt	http://www.wikidata.org/prop/direct/
wdtn	http://www.wikidata.org/prop/direct-normalized/
schema	http://schema.org/
skos	http://www.w3.org/2004/02/skos/core#
rdfs	http://www.w3.org/2000/01/rdf-schema#
wikibase	http://wikiba.se/ontology#
p	http://www.wikidata.org/prop/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n12	http://dx.doi.org/10.1097/
n11	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdh	http://www.w3.org/2001/XMLSchema#
wds	http://www.wikidata.org/entity/statement/
wd	http://www.wikidata.org/entity/

Statements

Subject Item

wd:Q50639042

rdf:type

wikibase:Item

schema:description

artigo científico научни чланак 1999年学术文章 1999年の論文 научни чланак 1999년 논문 1999年學術文章 επιστημονικό άρθρο vitenskapelig artikkel artículu científicu наукова стаття, опублікована в березні 1999 мақолаи илмӣ 1999年学术文章 wetenschappelijk artikel artigo científico scientific article published in March 1999 teaduslik artikkel articol științific научная статья 1999年學術文章 บทความทางวิทยาศาสตร์ scienca artikolo artykuł naukowy artikull shkencor 1999年学术文章 videnskabelig artikel 1999年學術文章 vědecký článek মার্চ ১৯৯৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ scientific article published in March 1999 1999年学术文章 artigo científico bilimsel makale article científic 1999年学术文章 vetenskaplig artikel artículo científico publicado en 1999 article scientific 1999 nî lūn-bûn articolo scientifico artikel ilmiah מאמר מדעי artikulong pang-agham tudományos cikk 1999年学术文章 1999年學術文章 مقالة علمية نشرت في مارس 1999 vitskapeleg artikkel article scientifique tieteellinen artikkeli научна статия scientific article published in March 1999 wissenschaftlicher Artikel 1999年學術文章 naučni članak სამეცნიერო სტატია bài báo khoa học vedecký článok

p:P577

wds:Q50639042-49AAB3D7-972F-4F52-9242-65B972A1296C

wdt:P577

1999-03-01T00:00:00Z

p:P407

wds:Q50639042-B4A38112-1EF0-4760-B3B3-113C0E19646F

wdt:P407

wd:Q1860

p:P2093

wds:Q50639042-4B61021F-9F0F-4078-97FC-DAB481DA3983 wds:Q50639042-3F6BEE0B-4122-487D-9DBD-DED75D1EFDEF wds:Q50639042-2AA7C75F-391B-404D-A072-9089A53DD151

wdt:P2093

H H Balfour D Aeppli S E Krown

rdfs:label

Phase II, randomized, open-label, community-based trial to compare the safety and activity of combination therapy with recombinant interferon-alpha2b and zidovudine versus zidovudine alone in patients with asymptomatic to mildly symptomatic HIV infe Phase II, randomized, open-label, community-based trial to compare the safety and activity of combination therapy with recombinant interferon-alpha2b and zidovudine versus zidovudine alone in patients with asymptomatic to mildly symptomatic HIV infe

skos:prefLabel

Phase II, randomized, open-label, community-based trial to compare the safety and activity of combination therapy with recombinant interferon-alpha2b and zidovudine versus zidovudine alone in patients with asymptomatic to mildly symptomatic HIV infe Phase II, randomized, open-label, community-based trial to compare the safety and activity of combination therapy with recombinant interferon-alpha2b and zidovudine versus zidovudine alone in patients with asymptomatic to mildly symptomatic HIV infe

schema:name

Phase II, randomized, open-label, community-based trial to compare the safety and activity of combination therapy with recombinant interferon-alpha2b and zidovudine versus zidovudine alone in patients with asymptomatic to mildly symptomatic HIV infe Phase II, randomized, open-label, community-based trial to compare the safety and activity of combination therapy with recombinant interferon-alpha2b and zidovudine versus zidovudine alone in patients with asymptomatic to mildly symptomatic HIV infe

p:P1476

wds:Q50639042-0F3F7B76-9126-4BF8-94D9-9F1C8A93E8CE

wdt:P1476

Phase II, randomized, open-label, community-based trial to compare the safety and activity of combination therapy with recombinant interferon-alpha2b and zidovudine versus zidovudine alone in patients with asymptomatic to mildly symptomatic HIV infe

p:P304

wds:Q50639042-56F221CD-6A29-4CA0-AE16-9CADE4FEA298

wdt:P304

245-254

p:P31

wds:Q50639042-A60602AE-8A72-4EEB-B98D-B0D10AA11D61

wdt:P31

wd:Q13442814

p:P921

wds:Q50639042-95EA513D-91FC-4F43-A4E0-CAD4BD29E57F wds:Q50639042-C5644858-02B1-486C-9408-400B21929DC3

wdt:P921

wd:Q42824440 wd:Q198504

p:P698

wds:Q50639042-11F55D7D-D103-4EA3-8D30-17040F15A612

wdtn:P698

n11:10077172

wdt:P698

10077172

p:P1433

wds:Q50639042-C86B62DF-F30E-4879-AA18-B4B5D1FF7A78

wdt:P1433

wd:Q6294722

p:P433

wds:Q50639042-2D273934-9F84-43DD-9F68-83EE9641D515

p:P478

wds:Q50639042-459ED077-543F-4D1E-A718-825088A2ADE4

wdt:P433

3

wdt:P478

20

p:P356

wds:Q50639042-7CCC2C3E-2F86-4B7A-A77D-43D8935F7A86

wdtn:P356

n12:00042560-199903010-00005

wdt:P356

10.1097/00042560-199903010-00005